Stockreport

Deciphera Pharmaceuticals, Inc. Expands Pipeline with Potential First-in-Class Autophagy Inhibitor to Treat Mutant RAS Cancers

Deciphera Pharmaceuticals, Inc.  (DCPH) 
Last deciphera pharmaceuticals, inc. earnings: 3/9 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: deciphera.com/investor-relations
PDF - DCC-3116 Selectively Targets ULK Kinase, an Initiating Protein that Activates Autophagy - - Company to Host a Webcast on Tuesday, June 18, 2019 [Read more]